Medical Marijuana will soon make its debut in the Chicago suburbs this November with the opening of a new Buffalo Grove dispensary on 1623 Barclay Blvd. The facility is owned by Professional Dispensaries of Illinois (“PDI”), an impressively credentialed company that seeks to set high standards for the budding industry by ensuring pharmacist supervision and partnering with local PD. Both of these moves exceed state-mandated standards for quality control and safety, as Illinois does not require pharmacists for the distribution of medical Marijuana, and PDI’s security and confidentiality protocols exceed regulations set forth by the state’s Medical Cannabis Pilot Program.
Owner, Dr. Mark H. Mandel, PharmD, and Chief Operating Officer, Joseph Friedman, R.Ph, MBA, chose an opportune time to open shop, as the Illinois medical Marijuana market may soon expand. This is because on October 7, 2015, the Illinois Medical Cannabis Advisory Board recommended eight new qualifying conditions for its medical marijuana program, a relief for patients after eleven suggested qualifying conditions were rejected by Governor Rauner last month. If the eight new conditions are approved, it will enlarge Illinois’ medical Marijuana customer base by broadening patient eligibility. Buffalo Grove officials have welcomed the dispensary’s opening, as it is likely to yield significant tax revenue and will garner positive press for the village as an early-adopter within a promising new industry.